FINANCE87 Videos

0

The Latest “Buzz on the Street” Show: Featuring Canopy Growth Collaboration

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced the next phase in its partnership with Parent Action on Drugs (“PAD”) and Canadian Students for Sensible Drug Policy (“CSSDP”) which will see PAD launch two new digital tools to help youth along with their parents, adult caregivers, and influencers, on how to make responsible decisions about […]

0

“Behind the Buzz” Show: Field Trip Ventures Inc. Co-Founder Ronan Levy

Field Trip Ventures Inc.’s mission is to heal the sick, and better the well, through therapeutic psychedelics. Field Trip is a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics value chain — from basic research on botanical psychedelics to operation of world class clinics focused on psychedelics-assisted […]

0

“Buzz on the Street” Show: Featuring MediPharm Labs (OTCQB: MLCPF) (TSX-V: LABS) News

MediPharm Labs Corp. (OTCQB: MLCPF) (TSX-V: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has entered into its first definitive international sales agreement, dated February 20, 2019, with AusCann Group Holdings Ltd. to supply private label purified, pharmaceutical grade cannabis oil concentrates, or resin, from MediPharm Labs’ own inventory of oil […]

0

“Buzz on the Street” Show: Nov. 18, 2019 Retail Earnings Focus for the Week (NYSE: HD TGT LOW M)

Home Depot, Inc. (NYSE: HD) reports its third-quarter results on Tuesday morning with analysts expecting an EPS of $2.53 cents and sales of 27.5 billion dollars. Then Wednesday morning will see Target Corp. (NYSE: TGT) and Lowe’s Companies, Inc. (NYSE: LOW) report their 3rd quarter results with analysts estimating an EPS of $1.19 cents and […]

0

“Buzz on the Street” Show: Featuring Blueberries Medical (OTC: BBRRF) (CSE: BBM) News

Blueberries Medical Corp. (OTC: BBRRF) (CSE: BBM) announced that it has entered into a letter of intent for a joint venture with India Colorada S.A.S., one of the leading Colombian artisanal brewers and producer of the oldest craft beer in Colombia, Cerveza Colón, to research, develop and commercialize non-alcoholic cannabis-based beverages Blueberries Medical is seeking […]

0

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Patent to Treat Retinal Disorders

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary MANF Therapeutics has been issued a Chinese patent covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF) and/or cerebral dopamine neurotrophic factor (CDNF) for the […]

0

“Buzz on the Street” Show: Stock Market Retail Report (NYSE: KSS TGT LB) (NASDAQ: URBN)

Kohl’s Corporation (NYSE: KSS) shares tanked by more than 16% on Tuesday after the Company reduced its outlook and missed analyst expectations with earnings of 0.74 cents on revenues of $4.36 billion Then, Urban Outfitters, Inc. (NASDAQ: URBN) slumped more than 14% on Wednesday after it reported earnings of 56 cents per share and revenues […]

0

“Buzz on the Street” Show: Q BioMed (OTCQB: QBIO) Mannin Research Reports Data: Acute Kidney Injury

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC. Q BioMed Inc. […]

0

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Eltoprazine & CBD to Treat Parkinson’s

Amarantus Bioscience Holdings, Inc. (OTC: AMBS) (“Amarantus,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary Elto Pharma, Inc. has received a notice of allowance from the European Patent Office (EPO) covering the use of eltoprazine and eltoprazine […]

0

“Buzz on the Street” Show: Stock Market Report (NYSE: CRM RH WORK) (NASDAQ: EXPE)

Salesforce.com, Inc. (NYSE: CRM) released its third quarter results on Tuesday evening, surpassing revenue and earnings, yet still trended downwards as its largest ever acquisition handed the company a net loss for the quarter, and an EPS of 75 cents and revenues of 4.5 billion dollars were not enough to appease investors. Then the Expedia […]